Wisconsin cancer facility uses Xoft e-brachytherapy to treat skin cancer
The University of Wisconsin (UW) Cancer Center Riverview became the first medical facility to treat skin cancer patients using Xoft's electronic brachytherapy system, Axxent, in early July.
The Riverview center initiated treatments on three patients with non-melanoma skin cancers under the direction of James S. Welsh, MD, the center's radiation oncologist and a clinical professor in the department of human oncology and medical physics at the UW in Madison. Welsh collaborated with Yi Rong, PhD, chief medical physicist at Riverview, on the planning and delivery of the treatments.
Located within Riverview Hospital in Wisconsin Rapids, Wis., the UW Cancer Center Riverview used electronic brachytherapy--which utilizes a miniaturized x-ray source, rather than radioactive isotopes--to deliver a therapeutic dose to a cancer tumor, according to the Sunnyvale, Calif.-based company.
The Riverview center initiated treatments on three patients with non-melanoma skin cancers under the direction of James S. Welsh, MD, the center's radiation oncologist and a clinical professor in the department of human oncology and medical physics at the UW in Madison. Welsh collaborated with Yi Rong, PhD, chief medical physicist at Riverview, on the planning and delivery of the treatments.
Located within Riverview Hospital in Wisconsin Rapids, Wis., the UW Cancer Center Riverview used electronic brachytherapy--which utilizes a miniaturized x-ray source, rather than radioactive isotopes--to deliver a therapeutic dose to a cancer tumor, according to the Sunnyvale, Calif.-based company.